Co-founded by a physician and a dentist, the platform was built on the belief that obesity care should be rooted in science, free of stigma, and available to anyone who needs it, no matter where they live
Disrupted care is not managed care
The control group required greater use of inotropic and vasoactive infusions during the 48 h period after CABG to achieve the same hemodynamic results observed in the group receiving GLP-1
Multi-state reach means multi-state licensing, one of the slowest parts of launching (more on this below)
Weight Loss Injections and Meal Replacements: A Powerful Combination for Effective Weight Management In recent years, the landscape of weight loss strategies has evolved dramatically, with GLP-1 weight loss injections emerging as a game-changer for many individuals struggling with obesity
Associations of semaglutide with Alzheimers disease-related dementias in patients with type 2 diabetes: a real-world target trial emulation study